MARCKS and melanoma: To investigate whether the increased expression and activity of MARCKS affects these invasive events in BRAFi-R melanoma cells, we performed loss-of-function experiments in BRAFi-R1 and BRAFi-R2 A375 melanoma cells by employing two independent MARCKS-targeting siRNA oligonucleotides.